Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: A randomized controlled trial

Pediatric Cardiology

Volumn 35, Issue 5, 2014, Pages 824-830

  Yadav, Sanju ^a   Agarwal, Sheetal ^a   Maria, Arti ^a   Dudeja, Ajay ^b   Dubey, N K ^a   Anand, Puneet ^a   Yadav, Dinesh Kumar ^a,c  

^a DR RAM MANOHAR LOHIA HOSPITAL   (India)

^b LHMC   (India)

^c Division of Neonatalogy Department of Pediatrics Dr RML Hospital ^*  (India)

Author keywords

Indomethacin; Oral ibuprofen; PDA closure; Preterm

Indexed keywords

IBUPROFEN; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTERY LIGATION; ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GESTATIONAL AGE; HUMAN; IMAGING SYSTEM; INDIA; M MODE ECHOCARDIOGRAPHY; MALE; MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN; OLIGURIA; PATENT DUCTUS ARTERIOSUS; PERSISTENT PULMONARY HYPERTENSION; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; THROMBOCYTE COUNT; TREATMENT INDICATION; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY; UREA NITROGEN BLOOD LEVEL; DUCTUS ARTERIOSUS, PATENT; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; IBUPROFEN; INDIA; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; MALE; TREATMENT OUTCOME;

EID: 84902548392     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-014-0861-2     Document Type: Article

References (30)

1. Aly H, Lofty W, Badrawi N et al (2007) Oral ibuprofen and ductus arteriosus in premature infants: a randomized pilot study. Am J Perinatol 24:267-270 (Pubitemid 46878753)
2. Barzilay B, Youngster I, Batash D et al (2012) Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants. Arch Dis Child Fetal Neonatal Ed 97(2):F116-F119
3. Bernstein D (1999) Congenital heart disease. In: Behrman ER, Kliegman RM, Jenson HB (eds) Nelson textbook of pediatrics, 16th edn. Saunders Company, Philadelphia, pp 1362-1413
4. Cherif A, Khrouf N, Jabnoun S et al (2008) Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics 122:e1256-e1261
5. Chotigeat U, Jirapapa K, Layangkool T (2003) A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai 86(Suppl 3):S563-S569 (Pubitemid 38009742)
6. Clyman RI (1996) Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr 128:601-607
7. Clyman RI, Chome N (2007) Patent ductus arteriosus: evidence for and against treatment. J Pediatr 150:216-219 (Pubitemid 46328984)
8. Fakhraee SH, Badiee Z, Mojtahedzadeh S et al (2007) Comparison of oral ibuprofen an indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi 9:399-403 (Pubitemid 47611418)
9. Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD (1997) Patent arterial duct. I: genetic and environmental risk factors of major cardiovascular malformations. The Baltimore-Washington Infant Study 1981-1989. Fuytura Publishing Co., Inc, Armonk, pp 285-299
10. Heymann MA, Rudolph AM, Silverman NH (1976) Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 295(10):530-533
11. Hirt D, Van Overmeire B, Treluyer JM et al (2008) An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol 65:629-636 (Pubitemid 351535097)
12. Kumar RK, Yu VYH (1997) Prolonged low-dose indomethacin therapy for patent ductus arteriosus in very low birthweight infants. J Paediatr Child Health 33:38-41 (Pubitemid 27104230)
13. Mehta SK, Younoszai A, Pietz J, Achanti BP (2003) Pharmacological closure of the patent ductus arteriosus. Images Paediatr Cardiol 5(1):1-15
14. Ohlsson A, Walia R, Shah SS (2010) Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (4):CD003481
15. Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD (1995) Ibuprofen treatment of patent ductus arteriosus. Lancet 346:255
16. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD (2000) Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 47(1):36-42 (Pubitemid 30038889)
17. Pourarian Sh, Pishva N, Madani A, Rastegari M (2008) Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants. East Mediterr Health J 14:360-365 (Pubitemid 351888498)
18. Ravi Kumar BP, Dudala SR, Rao AR (2013) Kuppuswamy's Socio-Economic Status Scale: a revision of economic parameter for 2012. Int J Res Dev Health 1(1):2-4
19. Richards J, Johnson A, Fox G, Campbell M et al (2009) A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants. Pediatrics 124(2):e287-e293
20. Sharma PK, Garg SK, Narang A (2003) Pharmacokinetics of oral ibuprofen in premature infants. J Clin Pharmacol 43:968-973 (Pubitemid 37022740)
21. Su BH, Watanabe T, Shimizu M, Yanagisawa M (1997) Echocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants. Arch Dis Child Fetal Neonatal Ed 77:F36-F40 (Pubitemid 28201626)
22. Su BH, Lin HC, Chiu HY, Hsieh HY, Chen HH, Tsai YC (2008) Comparison of ibuprofen and indomethacin for early targeted treatment of patent ductus arteriosus in extremely premature infants a randomized controlled trial. Arch Dis Child Fetal Neonatal Ed 93:F94-F99
23. Supapannachart S, Limrungsikul A, Khowsathit P (2002) Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai 85(Suppl 4):S1252-S1258 (Pubitemid 36255069)
24. Treluyer JM, Gueret G, Cheron G, Sonnier M, Cresteil T (1997) Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in vivo/in vitro correlation and inducibility. Pharmacogenetics 7:441-452 (Pubitemid 27517572)
25. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ (1997) Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed 76:F179-F184
26. Van Overmeire B, Smets K, Lecoutere D et al (2000) A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Eng J Med 343:674-681
27. Varvarigou A, Bardin CL, Beharry K et al (1996) Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 275:539-544 (Pubitemid 26061429)
28. Weir FJ, Ohlsson A, Myhr TL et al (1999) A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity. Eur J Pediatr 158:484-487 (Pubitemid 29240802)
29. Weiss H, Cooper B, Brook M, Schlueter M, Clyman R (1995) Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin. J Pediatr 127:466-471
30. Wong AR, Ramli N et al (2010) Closure of the patent ductus arteriosus with ibuprofen and other non-steroidal anti inflammatory medications in neonates. East J Med 15:139-145